AI, Hope, and the Future of Healing: Protecting All Kinds of Kids (and Furkids)
Artificial intelligence is often discussed in terms of productivity, automation, and economic transformation. Yet the most profound impact of AI may ultimately be something far more meaningful: helping our loved ones heal. Someday—perhaps sooner than many expect—AI may play a central role in treating cancers, developing personalized medicine, and protecting the ones we love most. For many families that means human children. For others, our “kids” walk on four legs, greet us at the door with wagging tails, and hold a place in our hearts that is no less real.
————–
For those of us who do not have human children, our kids are often of the four‑legged variety. Dogs, in particular, become family in every sense of the word. Anyone who has loved a dog knows that the bond is not abstract—it is deeply personal. We celebrate their joys, worry when they are sick, and would do nearly anything in our power to protect them and help them heal.
That is why I was struck by an extraordinary story that every dog owner should know about.
The story involves Paul Conyngham, an Australian technology researcher working in the AI field. When his beloved shar‑pei mix was diagnosed with a life‑threatening mast cell cancer, Paul refused to simply accept the situation and hope for the best. Instead, he embarked on a remarkable journey that blended persistence, scientific collaboration, and the emerging power of artificial intelligence.
With the help of researchers and modern AI tools, Paul helped guide the development of a custom mRNA cancer vaccine designed specifically for his dog’s tumor profile. Creating such a treatment required substantial cost, effort, and perseverance. Yet the results were remarkable enough to capture international attention: the experimental vaccine helped shrink some of his dog’s tumors.
While this story is inspiring on its own, the broader implications are even more breathtaking.
Scientists have long suspected that one of the future frontiers of cancer treatment lies in personalized vaccines—treatments custom‑built to recognize and attack the unique genetic signatures of cancer cells in an individual patient. AI has the potential to dramatically accelerate this process by analyzing massive datasets, identifying mutation patterns, and helping researchers design highly targeted therapies faster than traditional methods allow.
In other words, AI could eventually help doctors create precision treatments tailored not just to a type of cancer, but to the exact cancer in a specific patient.
Today we see early examples of this promise in both human and veterinary medicine. Tomorrow, AI‑assisted discovery could transform how we treat some of the most devastating diseases known to science.
As a dog owner who would do anything to protect his “kids,” this story was deeply moving. But it also resonated with me professionally. At ParksPacific Bookkeeping, we spend a great deal of time thinking about how artificial intelligence can improve the way businesses operate—from financial analysis and forecasting to smarter decision‑making and operational efficiency.
The same technology that helps a business owner better understand cash flow or automate routine accounting tasks is part of a much larger technological movement. AI is becoming a tool that augments human intelligence across industries—from finance and logistics to medicine and scientific discovery.
Businesses that learn to responsibly adopt AI today are not just improving their bottom line. They are participating in a broader ecosystem that helps drive innovation, research, and technological progress.
And that progress matters.
Science saves lives. Medical research saves lives. Sometimes those lives belong to strangers. Sometimes they belong to someone you love. And sometimes they belong to the loyal companion sleeping at the foot of your bed.
If we want a future where stories like Paul Conyngham’s become more common—where cancer treatments become smarter, faster, and more personalized—we must support the institutions that make scientific discovery possible.
That means supporting research. Supporting technological innovation. And yes, supporting leaders who believe in science rather than fearing it.
Because the breakthroughs of tomorrow may very well save the lives of our children—whether they walk on two legs or four.
Author’s Reflection: Questions Worth Considering
This story is inspiring, but it is also important to approach it thoughtfully. Experimental treatments and personalized vaccines are still emerging technologies, and individual success stories do not always translate into widely available medical solutions. Regulatory oversight, safety testing, and rigorous clinical trials remain essential before such treatments become mainstream.
In addition, AI is a tool—not a miracle. Human scientists, physicians, and researchers remain central to every breakthrough. AI can accelerate discovery, but responsible use, ethical oversight, and careful scientific validation must always guide its application.
Still, the trajectory is clear: the combination of human ingenuity and intelligent tools is opening doors that were unimaginable only a decade ago. And that future is only going to happen if we only elect lawmakers who are PRO-science and not ANTI-science. Keep that in mind as you approach any ballot box.
Read more about Paul’s journey at: https://www.theaustralian.com.au/business/technology/tech-boss-uses-ai-and-chatgpt-to-create-cancer-vaccine-for-his-dying-dog/news-story/292a21bcbe93efa17810bfcfcdfadbf7?_bhlid=d320884ac84cf2fd6620e468c28e8056a070a951
Leave a Reply